surmount-1 tirzepatide trial obesity without diabetes SURMOUNT-MMO: First on for overweight/obese | Samu Shiva, MD posted on the topic SURMOUNT Clinical Trials Orals Session

doi: 10.3389/fcell.2024.1435125 Received 19 May 2024 Accepted 27 June 2024 Published 11 July 2024 Volume 12 - 2024 Edited by Takehito Ouchi, Tokyo Dental College, Japan Reviewed by Kui Xu, Anhui University of Chinese Medicine, China Xiaolei Li, University of Pennsylvania, United States Updates Copyright 2024 Zheng, Liu, Sun and Meng

References Reynolds, J

Switching from Other Medications to Tirzepatide If youre coming from semaglutide or other GLP-1 medications, your provider will likely have you start tirzepatide at its standard 2.5 mg weekly dose

Semaglutide and Cortisol: The Basics Semaglutide is a medication primarily used to treat type 2 diabetes and to help with weight loss in people who are overweight or obese

At 1.67mg/ml, a 0.25mg dose requires about 0.15ml (15 units)